|

IDE397 Clinical Trials

2 actively recruiting trials across 2 locations

Pipeline

Phase 1: 2

Top Sponsors

  • IDEAYA Biosciences2

Indications

  • Lung Cancer2
  • Cancer2
  • Squamous Cell Car. - Esophagus1
  • Adenocarcinoma of Esophagus1
  • Urothelial Carcinoma (UC)1

Scottsdale, Arizona1 trial

Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion

Honor Health Research Institute

Phase 1

Houston, Texas1 trial

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

NEXT Oncology Houston

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.